Table 1.
Study | Status | Age at baseline mean (SD) | UPSIT score (mean, SD) | Male (%) | Positive family history of PD (%) | Inferred Ashkenazi ancestry (%) |
---|---|---|---|---|---|---|
PPMI | Case | 61.75 (9.69) | 23.48 (8.35) | 65.57 | 25.53 | 6.09 |
Control | 60.61 (10.43) | 34.18 (4.71) | 63.74 | 5.85 | 11.11 | |
PDBP | Case | 64.59 (8.99) | 19.65 (8.01) | 64.18 | 24.88 | 3.61 |
Control | 62.87 (10.96) | 32.52 (5.98) | 45.25 | 8.14 | 4.07 |
AMP-PD accelerating medicines partnership in Parkinson’s disease, PPMI Parkinson’s progression marker initiative, PDBP Parkinson’s disease biomarker program, PD Parkinson’s disease, SD standard deviation, UPSIT University of Pennsylvania smell identification test.